Rapid and extensive oscillations in rat heart adenine nucleotide content which could not be explained as metabolism of any known precursor, derivative or polymer caused us to propose the existence of some hitherto unrecognized derivative which exchanges rapidly with soluble nucleotides (for a review, see Lawson & Mowbray, 1986) . A subsequent search after selectively labelling tissue purine nucleotides revealed a labile highly phosphorylated oligometric substance at specific activity equilibrium with ATP in both heart (Mowbray et a[., 1984) and kidney (Hutchinson et al., 1986b) . Selective digestion allied to a variety of chromatographic techniques together with " P nuclear magnetic resonance spectroscopy and fast atom bombardment mass spectrometry has suggested that it is a linear oligomer of ATP and 3-phosphoglycerate of the form ppp(5'A3'p-3-glyceroyl-1 -ppp), SfA3'p3-glycerate (Hutchinson et al., 19860) . Work is currently in progress to confirm this structure by synthesizing the basic unit by a chemically unambiguous method.
This report describes the recognition and partial purification from rat heart of an enzyme which degrades this oligomer in an AMP-dependent fashion.
As with amino acid adenylates (Meister, 1963) and other mixed anhydrides of 5'-adenylic acid and a carboxylic acid (Jencks, 1963) , phosphoglyceroyl-ATP (PG-ATP) is rapidly hydrolysed non-enzymically at neutral pH. However, we have found that PG-ATP is progressively stabilized in neutral solution as the concentration of Mn2+ or Mg2+ ions is increased to 2 mM; by 5 mwion, PG-ATP survives incubation at 37°C for 30 min without evidence of degradation (data not shown). Hence we routinely add 5-1Om~-MgC1, to all PG-ATP solutions. The [I4C]PG-ATP substrate is purified from perfused rat hearts as described by Hutchinson et al. (1986a) .
The assay used to survey cell fractions for their ability to degrade PG-ATP depends on the fact that the oligomer as purified is readily precipitated from 50% aqueous ethanol solution and can be trapped on a millipore (0.45pm) filter and assayed for radioactivity. The hydrolysed 8-['4C]purine nucleotide remains in solution and passes through the filter. The standard conditions used in the assay are approx. 5 nmol of PG-ATP (350d.p.m.), 1 mM-AMP, 5 mM-MgCI,, 14 m~-2-mercaptoethanol, 50 mM-potassium phosphate, pH 7.0 in a total volume of 3 5 0~1 . After IOmin incubation at 37"C, 35Opl of ethanol is added and the mixture chilled at -20°C for 2 h before being filtered. The radioactivity on the filter and in the filtrate is assayed in 4ml of PCS scintillation mixture (Amersham International Ltd., Amersham, U.K.).
Abbreviation used: PG-ATP, phosphoglyceroyl-ATP. Rat hearts were homogenized in 3 vol. of cold 14m~2-mercaptoethanol/50 mM-pOtaSSiUm phosphate buffer pH 7.0 using 2 x 2s bursts of an Ultraturrax homogenizer. The mixture was centrifuged at 90000g ave. for 90min and (NH,(,SO, (4070, w/v) added to the supernatant. The pellet containing 20-307 of the original protein was taken up in extraction buffer and applied to a Sephadex G-200 column (1.5cm x 30 cm) and developed a t 4°C with 180 mM-KCi/ 14 mhl-2-rnercaptoethanol/SO mwpotassium phosphate buffer pH 7.0. the absorbance at 280 nm was monitored and the AMP-promoted degradation of PG-ATP was measured in collected fractions dialysed before assay against 14 m~-2-mercaptoethanol. 50mM-potassium phosphate buffer pH 7.0 (see the text for details).
Rather surprisingly, given the prevalence of phosphatases in tissue extracts, dialysed homogenate of heart proved unable to degrade the magnesium salt of PG-ATP, poiniing to some extra stability thus conferred. By contrast the addition to the incubations of 1 mM-AMP led to the rapid solubilization of the radioactivity in the 50% ethanol solution. This degrading activity was found to reside in the soluble fraction of the tissue extract and to be very largely precipitated from this fraction by 40% (w/v) (NH,),SO, (data not shown). Fig. 1 shows that the enzyme, unlike the bulk of other proteins in this fraction, is not excluded from Sephadex G-200: it does, however, retain a tendency to aggregate which can be overcome by increasing the ionic strength of the buffer. This high salt has the disadvantage of inhibiting its activity against PG-ATP and hence the fractions require dialysis against low salt buffer before assaying. As a result of inflammatory stress, there is a rapid rise (within 12-24h) in the plasma concentration of glycoproteins synthesized by the liver apparently co-ordinated with the time course of the disease (Kushner, 1982; Pepys & Baltz, 1983) . The hepatic acute-phase secretory response has been well identified by observations in vivo (Baumann et a[.,  1983) , however, characterization in vitro has been subject to but few reports (Koj et al., 1984) .
A monocyte-derived mediator of the acute-phase response has been characterized as a 17000 dalton polypeptide recently named interleukin-I (IL-I), believed to initiate hepatocyte acute-phase protein synthesis and secretion (Dinarello, 1984) .
In this study we have used a rat hepatoma cell line MH, C , , known to secrete albumin and complement components, especially C9, and to metabolize testosterone and bilirubin.
Purified human interleukin-1 (Laboratory Impex Ltd., U.K.) caused stimulation of M H , C , cells in microtitre well culture to release the acute-phase reactant C-reactive protein in a dose-dependent manner (Fig. 1) . The replication of the M H , C , cell line was found not to be influenced by IL-l as measured by cell count and tritiated thymidine incorporation. Lithium (1 mmol/l) caused complete inhibition of IL-l stimulated C-reactive protein release from the , 1976) . However, we came to the conclusion that the kinetic method is subject to errors, not only because deproteinizing agents are inhibitory, but because the liver itself contains an acid-stable inhibitor of citrulline synthesis. This, in part, explained the lower concentrations of N-acetylglutamate that had been reported with the kinetic method than when the activator was measured as glutamate (see Lund & Wiggins, 1984) . However, the kinetic method, if suitably modified for reliable assay of crude tissue extracts. would be quicker by far and more convenient. This paper is concerned with our efforts to achieve this.
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There were three obstacles: (i) all deproteinizing agents (HCIO,, trichloroacetic acid, sulphosalicylic acid, HCI, HzSO,) are inhibitory after neutralization of the liver extract with KOH or after ether-extraction of trichloroacetic acid; (ii) liver mitochondria and cytosol contain an acid-and heat-stable inhibitor of carbamoyl phosphate synthetase; (iii) published assay methods are too insensitive to the amounts of N-acetylglutamate (up to 10nmol) present in an assayable volume of tissue extract.
The inhibition of citrulline synthesis by neutral, deproteinized extracts is variable and not proportional to the amount of extract. The minimum inhibitions are about 30% by 0.1 ml of liver extract (1 part tissue/2 parts acid) after deproteinization with 0.5 M-HCI and about 50% after HCIO,, but were often much greater and include the effects of the endogenous inhibitor. Correction for recovery of N-acetylglutamate standards in the presence of an equal amount of neutralized deproteinizing agent does not provide an adequate control. Some properties of the endogenous inhibitor are that it inhibits non-competitively with N-acetylglutamate: recovery of standards (2-1 6 nmol) is inhibited by approx. 15% by 0.1 ml and 2&25' /0 by 0.2ml of boiled liver extract (1 part tissue/2 parts H,O) in the assay
